In 2016, I was appointed as a Research Fellow at the University of Manchester and began to lead a research group tackling themes centered around understanding the crosstalk between immune responses, stromal cells and the extracellular matrix (ECM) environment, with a particular emphasis on the lung. My early career training was in pharmacology and drug design, and I moved from Australia to the UK in 2007 applying my multidisciplinary background to understanding lung tissue repair and extracellular matrix remodeling from an immunological basis, publishing several seminal papers.  With the move to Manchester, I expanded this research to focus in greater depth on the relationship between immune cells and the extracellular matrix, placing me at the forefront of this understudied research area. My lab asks fundamental question about how cells position themselves within the local tissue environment during diseases like asthma, fibrosis and COVID-19 and aligns perfectly within the Lydia Becker Institute of Immunology and Inflammation and the Wellcome Centre for Cell Matrix Research at Manchester.